Stock Analysis of ABVC Biopharma Inc (ABVC) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABVC
Close 0.826
Change -0.069 / 7.67 %
Volume 88500.00
Vol Change -63621.00 / 41.82 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index No Significant Growth
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of ABVC Biopharma Inc


Highs/Lows of ABVC Biopharma Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.791 4.42 % 1.97 % 0.9690.78117-Jul-2415-Jul-24
Two Week0.74 11.62 % 1.12 % 0.9690.740117-Jul-2408-Jul-24
One Month0.7225 14.33 % 0.327 % 0.9690.70517-Jul-2421-Jun-24
Three Month0.9901 16.57 % 10.83 % 1.730.70525-Apr-2421-Jun-24
Six Months1.25 33.92 % 13.74 % 1.730.70525-Apr-2421-Jun-24
One year4.2 80.33 % 20.57 % 6.870.69726-Jul-2306-Oct-23
Two year8.35 90.11 % 39.84 % 18.70.69705-Jan-2306-Oct-23
Five year107.0 99.23 % 84.94 % 18.70.33305-Jan-2324-Jul-23
Ten year0.0031837 25844.66 % 178.28 % 29.953.1837E-410-May-2122-Jan-15


Technical View of ABVC Biopharma Inc






Charts of ABVC Biopharma Inc


Returns of ABVC Biopharma Inc with Peers
Period / StockABVCMBIOMBRXPSTV
1 Week4.42%-20.01%-0.805%-4.40%
1 Mth14.33%-62.25%8.42%-9.84%
3 Mth-16.57%-6.06%-7.20%6.75%
6mth-33.92%-76.23%-47.40%-19.07%
1 Year-80.33%-93.61%-56.62%-19.44%
2 Year-90.11%-96.56%-84.62%-76.80%
5 Years-99.23%-99.34%-95.94%-99.02%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of ABVC Biopharma Inc with Peers
Ratio / StockABVCMBIOMBRXPSTV
PE-0.515-38.81-79.86-93.17
P/B0.869182.1663.473089.57
ROA-67.01-128.86-64.87-97.90
ROE-165.44-469.37-79.48-3316.06
Debt To Equity0.2444.230.0038-3.04
Revenue739259
23.77 %
0
%
0
%
224000
0 %
Net Income-12268.66 K
24.79 %
-62620.00 K
19.23 %
-26270.00 K
9.49 %
-15164.00 K
25.21 %


Technicals of ABVC Biopharma Inc with Peers
Technical / StockABVCMBIOMBRXPSTV-
ADX18.2336.3421.1322.93
CMF0.248-0.5440.076-0.237
MFI76.0651.9553.9478.85
RSI50.6441.4956.1247.39
MACD Abv SignalTrueFalseTrueTrue
Price Above 50 MAFalseFalseTrueFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : ABVC Biopharma Inc


Address : 44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
Tel : (510)-668-0881
URL : https://www.abvcpharma.com
Code : ABVC, ISIN : US00091F1066, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 11_Oct_2017
Employee Count : 16

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.


Note : All Data Generated at the End of Trading Hours (EOD Data)